M. Kathleen Behrens founded Kew, Inc. Presently, she is Chairman at Sarepta Therapeutics, Inc.
She is also on the board of IGM Biosciences, Inc.
In the past Dr. Behrens occupied the position of Chairman & President at National Venture Capital Association, President & Chief Executive Officer of Kew, Inc., Director-Science, Technology & Economic Policy at The National Research Council, Managing Director & General Partner at Robertson Stephens & Co. and Managing Director at RS Investment Management Co. LLC.
Dr. Behrens received an undergraduate degree and a doctorate from the University of California, Davis.